Arthrosamid® is a next-generation injectable treatment for knee osteoarthritis. It is designed to provide long-lasting pain relief and enhanced joint function, particularly for individuals who have not responded well to conventional therapies such as steroid injections, physiotherapy, or oral medications.
The treatment involves a single injection of a hydrogel composed of 97.5% water and 2.5% cross-linked polyacrylamide. Once injected into the knee joint, Arthrosamid® cushions the joint and integrates with the synovial membrane—the soft tissue lining the joint capsule. This integration helps reduce inflammation, stiffness, and pain, while improving overall joint mobility.
Unlike traditional Visco supplement injections, Arthrosamid® becomes part of the joint lining, offering sustained relief that can last for up to three years or more.
It is particularly effective in advanced osteoarthritis, including cases where cartilage has worn down significantly—commonly referred to as “bone-on-bone” arthritis.